Breaking News Instant updates and real-time market news.

SRNE

Sorrento Therapeutics

$5.25

-0.2 (-3.67%)

07:31
12/01/16
12/01
07:31
12/01/16
07:31

Sorrento Therapeutics subsidiary updates pipeline progress

Sorrento Therapeutics subsidiary TNK Therapeutics has provided an update on its lead chimeric antigen receptor expressing T cells programs for the treatment of hematological malignancies. Sorrento intends to present these findings at upcoming clinical conferences and in scientific publications. The anti-CD38 CAR-T program is in development for the treatment of multiple myeloma. TNK has developed a proprietary second generation anti-CD38 CAR based on a fully human anti-CD38 monoclonal antibody derived from Sorrento's G-MAB antibody library. CD38-expressing multiple myeloma tumor cells were killed efficiently in vitro, and the CD38 CAR-T cells completely eradicated tumors in a xenograft mouse model of human multiple myeloma. The anti-CD123 CAR-T program is in development for the treatment of acute myeloid leukemia. IND Filings are planned for H1 2017, with initiation of Phase 1 clinical studies expected in H2 2017.

  • 06

    Dec

SRNE Sorrento Therapeutics
$5.25

-0.2 (-3.67%)

12/22/15
FBRC
12/22/15
INITIATION
Target $22
FBRC
Outperform
Sorrento Therapeutics initiated with an Outperform at FBR Capital
FBR Capital analyst Ed White started Sorrento Therapeutics with an Outperform rating and $22 price target.
12/22/15
12/22/15
INITIATION

On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AVANGRID (AGR) initiated with a Neutral at JPMorgan... Accuray (ARAY) initiated with a Sector Perform at RBC Capital... American Express (AXP) initiated with a Market Perform at JMP Securities... BioTime (BTX) initiated with an Outperform at Oppenheimer... Biota Pharmaceuticals (BOTA) initiated with an Outperform at FBR Capital... Box (BOX) initiated with an Outperform at JMP Securities... CNO Financial (CNO) initiated with an Outperform at Raymond James... Capital One (COF) initiated with a Hold at Evercore ISI... Criteo (CRTO) initiated with a Buy at SunTrust... CyberArk (CYBR) initiated with a Hold at Evercore ISI... CyrusOne (CONE) initiated with an Overweight at JPMorgan... Digital Realty (DLR) initiated with a Neutral at JPMorgan... Discover (DFS) initiated with a Hold at Evercore ISI... Etsy (ETSY) initiated with a Sell at Roth Capital... Fenix Parts (FENX) initiated with a Buy at Roth Capital... Fibrocell Science (FCSC) initiated with a Buy at Roth Capital... Franklin Electric (FELE) initiated with a Sell at Ladenburg... Harman (HAR) initiated with a Neutral at Susquehanna... Karyopharm (KPTI) initiated with a Buy at Canaccord... MPLX (MPLX) initiated with a Neutral at Credit Suisse... Marchex (MCHX) initiated with a Buy at Roth Capital... NantKwest (NK) initiated with a Buy at Canaccord... Nexstar (NXST) initiated with an Outperform at Barrington... Orbital ATK (OA) initiated with a Buy at CL King... Perrigo (PRGO) initiated with an Outperform at Northland... QTS Realty Trust (QTS) initiated with an Overweight at JPMorgan... RPC, Inc. (RES) initiated with a Buy at Guggenheim... Rubicon Project (RUBI) initiated with a Buy at SunTrust... Sorrento Therapeutics (SRNE) initiated with an Outperform at FBR Capital... Travelport (TVPT) initiated with a Neutral at SunTrust... TubeMogul (TUBE) initiated with a Buy at SunTrust... Ultragenyx (RARE) initiated with a Buy at Canaccord... Varian Medical (VAR) initiated with a Sector Perform at RBC Capital... Wayfair (W) initiated with a Neutral at SunTrust... Xencor (XNCR) initiated with a Buy at Canaccord.
01/25/16
BMUR
01/25/16
NO CHANGE
Target $15
BMUR
Buy
Sorrento Therapeutics should be bought aggressively, says Brean Capital
Brean Capital said they would be aggressive buyers of Sorrento Therapeutics following the recent release of top-line Phase lll data for biosimilar antibodies of Eribtux and Remicade. The firm sees upside from the biosimilar products and possibility of a BD deal with an established U.S. based biotech company in the near-term. Brean Capital reiterated its Buy rating and $15 price target on Sorrento Therapeutics shares.
10/03/16
ROTH
10/03/16
INITIATION
Target $15
ROTH
Buy
Sorrento Therapeutics initiated with a Buy at Roth Capital
Roth Capital analyst Joseph Pantginis started Sorrento Therapeutics with a Buy rating and $15 price target.

TODAY'S FREE FLY STORIES

XPO

XPO Logistics

$62.63

1.785 (2.93%)

10:00
06/28/17
06/28
10:00
06/28/17
10:00
Periodicals
XPO tells Bloomberg 'several billion' dollar acquisition is possible »

XPO Logistics CEO Bradley…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jul

HYG

iShares iBoxx $ High Yield Corporate Bond

$88.17

0.13 (0.15%)

10:00
06/28/17
06/28
10:00
06/28/17
10:00
Options
Hefty put spread in High Yield Bond Fund »

Hefty put spread in High…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDC

Western Digital

$91.85

-0.81 (-0.87%)

09:55
06/28/17
06/28
09:55
06/28/17
09:55
Options
Western Digital put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRIP

TripAdvisor

$36.49

-0.18 (-0.49%)

, LNC

Lincoln National

$66.94

1.315 (2.00%)

09:55
06/28/17
06/28
09:55
06/28/17
09:55
Options
Early notable gainers among liquid option names on June 28th »

Notable gainers among…

TRIP

TripAdvisor

$36.49

-0.18 (-0.49%)

LNC

Lincoln National

$66.94

1.315 (2.00%)

GIS

General Mills

$56.79

1.27 (2.29%)

DO

Diamond Offshore

$10.77

0.2 (1.89%)

RIG

Transocean

$8.23

0.16 (1.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 12

    Jul

  • 03

    Aug

  • 14

    Nov

09:55
06/28/17
06/28
09:55
06/28/17
09:55
Conference/Events
House Financial Services Committee to hold a hearing »

The Monetary Policy &…

SBUX

Starbucks

$58.96

-0.68 (-1.14%)

09:53
06/28/17
06/28
09:53
06/28/17
09:53
Periodicals
Fecal bacteria found in ice at Costa, Starbucks, Caffe Nero, BBC reports »

A BBC investigation found…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

PWE

Penn West

09:50
06/28/17
06/28
09:50
06/28/17
09:50
Hot Stocks
Breaking Hot Stocks news story on Penn West »

Penn West trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:50
06/28/17
06/28
09:50
06/28/17
09:50
General news
Treasury Action: yields rebounded again »

Treasury Action: yields…

APDN

Applied DNA Sciences

$1.76

0.36 (25.71%)

09:47
06/28/17
06/28
09:47
06/28/17
09:47
Syndicate
Applied DNA Sciences raises $1.8M in a private placement »

Applied DNA Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
06/28/17
06/28
09:45
06/28/17
09:45
General news
Pending Home Sales Index to be reported at 10:00 »

May Pending Home Sales…

SSNLF

Samsung

09:44
06/28/17
06/28
09:44
06/28/17
09:44
Hot Stocks
Samsung to open $380M home appliance plant in South Carolina »

Samsung announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOMO

Momo

$37.06

-2.32 (-5.89%)

, BAC

Bank of America

09:40
06/28/17
06/28
09:40
06/28/17
09:40
Options
Unusually active option classes on open June 28th »

Unusual total active…

MOMO

Momo

$37.06

-2.32 (-5.89%)

BAC

Bank of America

JPM

JPMorgan

GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

XBI

SPDR S&P BIOTECH

C

Citi

P

Pandora

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 14

    Jul

  • 14

    Jul

  • 20

    Jul

  • 25

    Jul

  • 12

    Oct

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

AAP

Advance Auto Parts

09:39
06/28/17
06/28
09:39
06/28/17
09:39
Downgrade
Advance Auto Parts rating change  »

Follow up: Advance Auto…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRQR

ProQR Therapeutics

$5.03

-0.025 (-0.50%)

09:38
06/28/17
06/28
09:38
06/28/17
09:38
Syndicate
Breaking Syndicate news story on ProQR Therapeutics »

ProQR Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIS

General Mills

09:36
06/28/17
06/28
09:36
06/28/17
09:36
Technical Analysis
Technical View: General Mills trades higher after results and outlook »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 12

    Jul

SKYS

Sky Solar

$1.54

0.26 (20.31%)

09:35
06/28/17
06/28
09:35
06/28/17
09:35
Hot Stocks
Sky Solar engages lawyers to investigate conduct of former CEO »

Sky Solar Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

ADMS

Adamas Pharmaceuticals

$16.88

-0.51 (-2.93%)

09:35
06/28/17
06/28
09:35
06/28/17
09:35
Hot Stocks
Adamas Pharmaceuticals appoints Alfred Merriweather as CFO »

Adamas Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

UMC

UMC

09:35
06/28/17
06/28
09:35
06/28/17
09:35
Upgrade
UMC rating change  »

UMC upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:35
06/28/17
06/28
09:35
06/28/17
09:35
General news
U.S. NAR pending home sales preview: »

U.S. NAR pending home…

QCOM

Qualcomm

$55.43

-1.13 (-2.00%)

, NXPI

NXP Semiconductors

$109.52

-0.21 (-0.19%)

09:33
06/28/17
06/28
09:33
06/28/17
09:33
Recommendations
Qualcomm, NXP Semiconductors analyst commentary  »

Qualcomm could raise…

QCOM

Qualcomm

$55.43

-1.13 (-2.00%)

NXPI

NXP Semiconductors

$109.52

-0.21 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBI

CB&I

09:33
06/28/17
06/28
09:33
06/28/17
09:33
Upgrade
CB&I rating change  »

CB&I upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAP

Advance Auto Parts

09:33
06/28/17
06/28
09:33
06/28/17
09:33
Downgrade
Advance Auto Parts rating change  »

Advance Auto Parts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACN

Accenture

09:32
06/28/17
06/28
09:32
06/28/17
09:32
Hot Stocks
Accenture acquires Intrepid, terms not disclosed »

Accenture has acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

09:31
06/28/17
06/28
09:31
06/28/17
09:31
Downgrade
Toyota rating change  »

Toyota downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BEP

Brookfield Renewable

09:30
06/28/17
06/28
09:30
06/28/17
09:30
Downgrade
Brookfield Renewable rating change  »

Brookfield Renewable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.